nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP1A2—Progesterone—uterine cancer	0.0994	0.21	CbGbCtD
Ropivacaine—CYP2D6—Progesterone—uterine cancer	0.0819	0.173	CbGbCtD
Ropivacaine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0786	0.166	CbGbCtD
Ropivacaine—CYP3A4—Progesterone—uterine cancer	0.0521	0.11	CbGbCtD
Ropivacaine—CYP2B6—Doxorubicin—uterine cancer	0.0517	0.11	CbGbCtD
Ropivacaine—CYP1A2—Etoposide—uterine cancer	0.0445	0.0942	CbGbCtD
Ropivacaine—CYP2D6—Doxorubicin—uterine cancer	0.025	0.0529	CbGbCtD
Ropivacaine—CYP3A4—Etoposide—uterine cancer	0.0233	0.0493	CbGbCtD
Ropivacaine—CYP3A4—Doxorubicin—uterine cancer	0.0159	0.0336	CbGbCtD
Ropivacaine—Neuropathy—Doxorubicin—uterine cancer	0.000602	0.00118	CcSEcCtD
Ropivacaine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000597	0.00117	CcSEcCtD
Ropivacaine—Diarrhoea—Progesterone—uterine cancer	0.00059	0.00115	CcSEcCtD
Ropivacaine—Coma—Doxorubicin—uterine cancer	0.000586	0.00115	CcSEcCtD
Ropivacaine—Phlebitis—Epirubicin—uterine cancer	0.000584	0.00114	CcSEcCtD
Ropivacaine—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000579	0.00113	CcSEcCtD
Ropivacaine—Cardiac disorder—Etoposide—uterine cancer	0.000577	0.00113	CcSEcCtD
Ropivacaine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000576	0.00113	CcSEcCtD
Ropivacaine—Hepatic function abnormal—Epirubicin—uterine cancer	0.000576	0.00113	CcSEcCtD
Ropivacaine—Dizziness—Progesterone—uterine cancer	0.000571	0.00111	CcSEcCtD
Ropivacaine—Vascular purpura—Epirubicin—uterine cancer	0.000563	0.0011	CcSEcCtD
Ropivacaine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000561	0.0011	CcSEcCtD
Ropivacaine—Chills—Etoposide—uterine cancer	0.000557	0.00109	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000556	0.00109	CcSEcCtD
Ropivacaine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000553	0.00108	CcSEcCtD
Ropivacaine—Vomiting—Progesterone—uterine cancer	0.000549	0.00107	CcSEcCtD
Ropivacaine—Rash—Progesterone—uterine cancer	0.000544	0.00106	CcSEcCtD
Ropivacaine—Dermatitis—Progesterone—uterine cancer	0.000543	0.00106	CcSEcCtD
Ropivacaine—Phlebitis—Doxorubicin—uterine cancer	0.000541	0.00106	CcSEcCtD
Ropivacaine—Headache—Progesterone—uterine cancer	0.00054	0.00106	CcSEcCtD
Ropivacaine—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000535	0.00105	CcSEcCtD
Ropivacaine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000535	0.00105	CcSEcCtD
Ropivacaine—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000533	0.00104	CcSEcCtD
Ropivacaine—Back pain—Etoposide—uterine cancer	0.000523	0.00102	CcSEcCtD
Ropivacaine—Purpura—Epirubicin—uterine cancer	0.000522	0.00102	CcSEcCtD
Ropivacaine—Pain—Dactinomycin—uterine cancer	0.000521	0.00102	CcSEcCtD
Ropivacaine—Vascular purpura—Doxorubicin—uterine cancer	0.000521	0.00102	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00052	0.00102	CcSEcCtD
Ropivacaine—Muscle spasms—Etoposide—uterine cancer	0.00052	0.00102	CcSEcCtD
Ropivacaine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000517	0.00101	CcSEcCtD
Ropivacaine—Hypoglycaemia—Epirubicin—uterine cancer	0.000516	0.00101	CcSEcCtD
Ropivacaine—Nausea—Progesterone—uterine cancer	0.000512	0.001	CcSEcCtD
Ropivacaine—Osteoarthritis—Epirubicin—uterine cancer	0.000503	0.000984	CcSEcCtD
Ropivacaine—Feeling abnormal—Dactinomycin—uterine cancer	0.000503	0.000982	CcSEcCtD
Ropivacaine—Ill-defined disorder—Etoposide—uterine cancer	0.000502	0.000981	CcSEcCtD
Ropivacaine—Anaemia—Etoposide—uterine cancer	0.0005	0.000977	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000499	0.000975	CcSEcCtD
Ropivacaine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000497	0.000971	CcSEcCtD
Ropivacaine—Affect lability—Epirubicin—uterine cancer	0.000495	0.000968	CcSEcCtD
Ropivacaine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000493	0.000963	CcSEcCtD
Ropivacaine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000492	0.000962	CcSEcCtD
Ropivacaine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00049	0.000957	CcSEcCtD
Ropivacaine—Malaise—Etoposide—uterine cancer	0.000488	0.000953	CcSEcCtD
Ropivacaine—Vertigo—Etoposide—uterine cancer	0.000486	0.00095	CcSEcCtD
Ropivacaine—Purpura—Doxorubicin—uterine cancer	0.000483	0.000944	CcSEcCtD
Ropivacaine—Abdominal pain—Dactinomycin—uterine cancer	0.000482	0.000942	CcSEcCtD
Ropivacaine—Body temperature increased—Dactinomycin—uterine cancer	0.000482	0.000942	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000481	0.00094	CcSEcCtD
Ropivacaine—Cardiac arrest—Epirubicin—uterine cancer	0.000479	0.000935	CcSEcCtD
Ropivacaine—Hypoglycaemia—Doxorubicin—uterine cancer	0.000477	0.000933	CcSEcCtD
Ropivacaine—Mood swings—Epirubicin—uterine cancer	0.000477	0.000932	CcSEcCtD
Ropivacaine—Loss of consciousness—Etoposide—uterine cancer	0.000475	0.000929	CcSEcCtD
Ropivacaine—Cough—Etoposide—uterine cancer	0.000472	0.000922	CcSEcCtD
Ropivacaine—Convulsion—Etoposide—uterine cancer	0.000469	0.000916	CcSEcCtD
Ropivacaine—Hypertension—Etoposide—uterine cancer	0.000467	0.000912	CcSEcCtD
Ropivacaine—Osteoarthritis—Doxorubicin—uterine cancer	0.000466	0.00091	CcSEcCtD
Ropivacaine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000464	0.000908	CcSEcCtD
Ropivacaine—Chest pain—Etoposide—uterine cancer	0.00046	0.0009	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Epirubicin—uterine cancer	0.00046	0.000898	CcSEcCtD
Ropivacaine—Affect lability—Doxorubicin—uterine cancer	0.000458	0.000896	CcSEcCtD
Ropivacaine—Hypokalaemia—Epirubicin—uterine cancer	0.000458	0.000895	CcSEcCtD
Ropivacaine—Discomfort—Etoposide—uterine cancer	0.000455	0.000889	CcSEcCtD
Ropivacaine—Breast disorder—Epirubicin—uterine cancer	0.000455	0.000889	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000453	0.000886	CcSEcCtD
Ropivacaine—Hypersensitivity—Dactinomycin—uterine cancer	0.000449	0.000878	CcSEcCtD
Ropivacaine—Confusional state—Etoposide—uterine cancer	0.000445	0.00087	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000444	0.000868	CcSEcCtD
Ropivacaine—Cardiac arrest—Doxorubicin—uterine cancer	0.000443	0.000865	CcSEcCtD
Ropivacaine—Anaphylactic shock—Etoposide—uterine cancer	0.000441	0.000863	CcSEcCtD
Ropivacaine—Mood swings—Doxorubicin—uterine cancer	0.000441	0.000862	CcSEcCtD
Ropivacaine—Infection—Etoposide—uterine cancer	0.000438	0.000857	CcSEcCtD
Ropivacaine—Abdominal distension—Epirubicin—uterine cancer	0.000438	0.000856	CcSEcCtD
Ropivacaine—Asthenia—Dactinomycin—uterine cancer	0.000438	0.000855	CcSEcCtD
Ropivacaine—Thrombocytopenia—Etoposide—uterine cancer	0.000432	0.000845	CcSEcCtD
Ropivacaine—Tachycardia—Etoposide—uterine cancer	0.000431	0.000842	CcSEcCtD
Ropivacaine—Skin disorder—Etoposide—uterine cancer	0.000429	0.000838	CcSEcCtD
Ropivacaine—Hyperhidrosis—Etoposide—uterine cancer	0.000427	0.000834	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000425	0.000831	CcSEcCtD
Ropivacaine—Hypokalaemia—Doxorubicin—uterine cancer	0.000424	0.000828	CcSEcCtD
Ropivacaine—Breast disorder—Doxorubicin—uterine cancer	0.000421	0.000823	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000419	0.00082	CcSEcCtD
Ropivacaine—Diarrhoea—Dactinomycin—uterine cancer	0.000417	0.000815	CcSEcCtD
Ropivacaine—Hypotension—Etoposide—uterine cancer	0.000412	0.000806	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000411	0.000803	CcSEcCtD
Ropivacaine—Dysuria—Epirubicin—uterine cancer	0.000407	0.000795	CcSEcCtD
Ropivacaine—Abdominal distension—Doxorubicin—uterine cancer	0.000405	0.000792	CcSEcCtD
Ropivacaine—Paraesthesia—Etoposide—uterine cancer	0.000396	0.000775	CcSEcCtD
Ropivacaine—Dyspnoea—Etoposide—uterine cancer	0.000393	0.000769	CcSEcCtD
Ropivacaine—Hyperglycaemia—Epirubicin—uterine cancer	0.000392	0.000767	CcSEcCtD
Ropivacaine—Somnolence—Etoposide—uterine cancer	0.000392	0.000767	CcSEcCtD
Ropivacaine—Drowsiness—Epirubicin—uterine cancer	0.000388	0.000758	CcSEcCtD
Ropivacaine—Vomiting—Dactinomycin—uterine cancer	0.000388	0.000758	CcSEcCtD
Ropivacaine—Rash—Dactinomycin—uterine cancer	0.000384	0.000751	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Epirubicin—uterine cancer	0.00038	0.000743	CcSEcCtD
Ropivacaine—Jaundice—Epirubicin—uterine cancer	0.000378	0.000739	CcSEcCtD
Ropivacaine—Pain—Etoposide—uterine cancer	0.000377	0.000738	CcSEcCtD
Ropivacaine—Constipation—Etoposide—uterine cancer	0.000377	0.000738	CcSEcCtD
Ropivacaine—Urinary tract infection—Epirubicin—uterine cancer	0.000377	0.000737	CcSEcCtD
Ropivacaine—Dysuria—Doxorubicin—uterine cancer	0.000376	0.000736	CcSEcCtD
Ropivacaine—Haematuria—Epirubicin—uterine cancer	0.00037	0.000723	CcSEcCtD
Ropivacaine—Feeling abnormal—Etoposide—uterine cancer	0.000364	0.000711	CcSEcCtD
Ropivacaine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000363	0.00071	CcSEcCtD
Ropivacaine—Nausea—Dactinomycin—uterine cancer	0.000362	0.000708	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Etoposide—uterine cancer	0.000361	0.000705	CcSEcCtD
Ropivacaine—Drowsiness—Doxorubicin—uterine cancer	0.000359	0.000701	CcSEcCtD
Ropivacaine—Bradycardia—Epirubicin—uterine cancer	0.000354	0.000693	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000352	0.000688	CcSEcCtD
Ropivacaine—Urticaria—Etoposide—uterine cancer	0.000351	0.000685	CcSEcCtD
Ropivacaine—Jaundice—Doxorubicin—uterine cancer	0.00035	0.000684	CcSEcCtD
Ropivacaine—Rhinitis—Epirubicin—uterine cancer	0.000349	0.000682	CcSEcCtD
Ropivacaine—Abdominal pain—Etoposide—uterine cancer	0.000349	0.000682	CcSEcCtD
Ropivacaine—Body temperature increased—Etoposide—uterine cancer	0.000349	0.000682	CcSEcCtD
Ropivacaine—Urinary tract infection—Doxorubicin—uterine cancer	0.000349	0.000682	CcSEcCtD
Ropivacaine—Hypoaesthesia—Epirubicin—uterine cancer	0.000346	0.000677	CcSEcCtD
Ropivacaine—Urinary tract disorder—Epirubicin—uterine cancer	0.000344	0.000672	CcSEcCtD
Ropivacaine—Oedema peripheral—Epirubicin—uterine cancer	0.000343	0.00067	CcSEcCtD
Ropivacaine—Haematuria—Doxorubicin—uterine cancer	0.000342	0.000669	CcSEcCtD
Ropivacaine—Urethral disorder—Epirubicin—uterine cancer	0.000341	0.000667	CcSEcCtD
Ropivacaine—Bradycardia—Doxorubicin—uterine cancer	0.000328	0.000641	CcSEcCtD
Ropivacaine—Hypersensitivity—Etoposide—uterine cancer	0.000325	0.000635	CcSEcCtD
Ropivacaine—Tinnitus—Epirubicin—uterine cancer	0.000325	0.000635	CcSEcCtD
Ropivacaine—Cardiac disorder—Epirubicin—uterine cancer	0.000323	0.000632	CcSEcCtD
Ropivacaine—Rhinitis—Doxorubicin—uterine cancer	0.000323	0.000631	CcSEcCtD
Ropivacaine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000321	0.000627	CcSEcCtD
Ropivacaine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000318	0.000622	CcSEcCtD
Ropivacaine—Oedema peripheral—Doxorubicin—uterine cancer	0.000317	0.00062	CcSEcCtD
Ropivacaine—Asthenia—Etoposide—uterine cancer	0.000317	0.000619	CcSEcCtD
Ropivacaine—Urethral disorder—Doxorubicin—uterine cancer	0.000316	0.000617	CcSEcCtD
Ropivacaine—Chills—Epirubicin—uterine cancer	0.000312	0.000611	CcSEcCtD
Ropivacaine—Pruritus—Etoposide—uterine cancer	0.000312	0.00061	CcSEcCtD
Ropivacaine—Arrhythmia—Epirubicin—uterine cancer	0.000311	0.000608	CcSEcCtD
Ropivacaine—Mental disorder—Epirubicin—uterine cancer	0.000305	0.000596	CcSEcCtD
Ropivacaine—Erythema—Epirubicin—uterine cancer	0.000303	0.000592	CcSEcCtD
Ropivacaine—Diarrhoea—Etoposide—uterine cancer	0.000302	0.00059	CcSEcCtD
Ropivacaine—Tinnitus—Doxorubicin—uterine cancer	0.0003	0.000587	CcSEcCtD
Ropivacaine—Cardiac disorder—Doxorubicin—uterine cancer	0.000299	0.000584	CcSEcCtD
Ropivacaine—Tension—Epirubicin—uterine cancer	0.000297	0.000581	CcSEcCtD
Ropivacaine—Nervousness—Epirubicin—uterine cancer	0.000294	0.000575	CcSEcCtD
Ropivacaine—Back pain—Epirubicin—uterine cancer	0.000293	0.000573	CcSEcCtD
Ropivacaine—Dizziness—Etoposide—uterine cancer	0.000292	0.00057	CcSEcCtD
Ropivacaine—Muscle spasms—Epirubicin—uterine cancer	0.000291	0.00057	CcSEcCtD
Ropivacaine—Chills—Doxorubicin—uterine cancer	0.000289	0.000565	CcSEcCtD
Ropivacaine—Arrhythmia—Doxorubicin—uterine cancer	0.000288	0.000563	CcSEcCtD
Ropivacaine—Vision blurred—Epirubicin—uterine cancer	0.000286	0.000558	CcSEcCtD
Ropivacaine—Mental disorder—Doxorubicin—uterine cancer	0.000282	0.000552	CcSEcCtD
Ropivacaine—Ill-defined disorder—Epirubicin—uterine cancer	0.000281	0.00055	CcSEcCtD
Ropivacaine—Vomiting—Etoposide—uterine cancer	0.000281	0.000548	CcSEcCtD
Ropivacaine—Erythema—Doxorubicin—uterine cancer	0.00028	0.000548	CcSEcCtD
Ropivacaine—Anaemia—Epirubicin—uterine cancer	0.00028	0.000548	CcSEcCtD
Ropivacaine—Agitation—Epirubicin—uterine cancer	0.000279	0.000544	CcSEcCtD
Ropivacaine—Rash—Etoposide—uterine cancer	0.000278	0.000544	CcSEcCtD
Ropivacaine—Dermatitis—Etoposide—uterine cancer	0.000278	0.000543	CcSEcCtD
Ropivacaine—Headache—Etoposide—uterine cancer	0.000276	0.00054	CcSEcCtD
Ropivacaine—Tension—Doxorubicin—uterine cancer	0.000275	0.000538	CcSEcCtD
Ropivacaine—Malaise—Epirubicin—uterine cancer	0.000273	0.000534	CcSEcCtD
Ropivacaine—Nervousness—Doxorubicin—uterine cancer	0.000272	0.000532	CcSEcCtD
Ropivacaine—Vertigo—Epirubicin—uterine cancer	0.000272	0.000532	CcSEcCtD
Ropivacaine—Syncope—Epirubicin—uterine cancer	0.000272	0.000531	CcSEcCtD
Ropivacaine—Back pain—Doxorubicin—uterine cancer	0.000271	0.00053	CcSEcCtD
Ropivacaine—Muscle spasms—Doxorubicin—uterine cancer	0.00027	0.000527	CcSEcCtD
Ropivacaine—Loss of consciousness—Epirubicin—uterine cancer	0.000266	0.000521	CcSEcCtD
Ropivacaine—Cough—Epirubicin—uterine cancer	0.000265	0.000517	CcSEcCtD
Ropivacaine—Vision blurred—Doxorubicin—uterine cancer	0.000264	0.000517	CcSEcCtD
Ropivacaine—Convulsion—Epirubicin—uterine cancer	0.000263	0.000513	CcSEcCtD
Ropivacaine—Nausea—Etoposide—uterine cancer	0.000262	0.000512	CcSEcCtD
Ropivacaine—Hypertension—Epirubicin—uterine cancer	0.000262	0.000511	CcSEcCtD
Ropivacaine—Ill-defined disorder—Doxorubicin—uterine cancer	0.00026	0.000509	CcSEcCtD
Ropivacaine—Anaemia—Doxorubicin—uterine cancer	0.000259	0.000507	CcSEcCtD
Ropivacaine—Myalgia—Epirubicin—uterine cancer	0.000258	0.000504	CcSEcCtD
Ropivacaine—Chest pain—Epirubicin—uterine cancer	0.000258	0.000504	CcSEcCtD
Ropivacaine—Arthralgia—Epirubicin—uterine cancer	0.000258	0.000504	CcSEcCtD
Ropivacaine—Agitation—Doxorubicin—uterine cancer	0.000258	0.000504	CcSEcCtD
Ropivacaine—Anxiety—Epirubicin—uterine cancer	0.000257	0.000503	CcSEcCtD
Ropivacaine—Discomfort—Epirubicin—uterine cancer	0.000255	0.000498	CcSEcCtD
Ropivacaine—Malaise—Doxorubicin—uterine cancer	0.000253	0.000494	CcSEcCtD
Ropivacaine—Vertigo—Doxorubicin—uterine cancer	0.000252	0.000492	CcSEcCtD
Ropivacaine—Syncope—Doxorubicin—uterine cancer	0.000252	0.000492	CcSEcCtD
Ropivacaine—Confusional state—Epirubicin—uterine cancer	0.000249	0.000488	CcSEcCtD
Ropivacaine—Anaphylactic shock—Epirubicin—uterine cancer	0.000247	0.000483	CcSEcCtD
Ropivacaine—Loss of consciousness—Doxorubicin—uterine cancer	0.000247	0.000482	CcSEcCtD
Ropivacaine—Infection—Epirubicin—uterine cancer	0.000246	0.00048	CcSEcCtD
Ropivacaine—Cough—Doxorubicin—uterine cancer	0.000245	0.000478	CcSEcCtD
Ropivacaine—Shock—Epirubicin—uterine cancer	0.000243	0.000476	CcSEcCtD
Ropivacaine—Convulsion—Doxorubicin—uterine cancer	0.000243	0.000475	CcSEcCtD
Ropivacaine—Thrombocytopenia—Epirubicin—uterine cancer	0.000242	0.000473	CcSEcCtD
Ropivacaine—Hypertension—Doxorubicin—uterine cancer	0.000242	0.000473	CcSEcCtD
Ropivacaine—Tachycardia—Epirubicin—uterine cancer	0.000241	0.000472	CcSEcCtD
Ropivacaine—Skin disorder—Epirubicin—uterine cancer	0.00024	0.00047	CcSEcCtD
Ropivacaine—Hyperhidrosis—Epirubicin—uterine cancer	0.000239	0.000467	CcSEcCtD
Ropivacaine—Chest pain—Doxorubicin—uterine cancer	0.000239	0.000467	CcSEcCtD
Ropivacaine—Myalgia—Doxorubicin—uterine cancer	0.000239	0.000467	CcSEcCtD
Ropivacaine—Arthralgia—Doxorubicin—uterine cancer	0.000239	0.000467	CcSEcCtD
Ropivacaine—Anxiety—Doxorubicin—uterine cancer	0.000238	0.000465	CcSEcCtD
Ropivacaine—Discomfort—Doxorubicin—uterine cancer	0.000236	0.000461	CcSEcCtD
Ropivacaine—Hypotension—Epirubicin—uterine cancer	0.000231	0.000452	CcSEcCtD
Ropivacaine—Confusional state—Doxorubicin—uterine cancer	0.000231	0.000451	CcSEcCtD
Ropivacaine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000229	0.000447	CcSEcCtD
Ropivacaine—Infection—Doxorubicin—uterine cancer	0.000227	0.000444	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000225	0.00044	CcSEcCtD
Ropivacaine—Shock—Doxorubicin—uterine cancer	0.000225	0.00044	CcSEcCtD
Ropivacaine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000224	0.000438	CcSEcCtD
Ropivacaine—Insomnia—Epirubicin—uterine cancer	0.000224	0.000437	CcSEcCtD
Ropivacaine—Tachycardia—Doxorubicin—uterine cancer	0.000223	0.000437	CcSEcCtD
Ropivacaine—Skin disorder—Doxorubicin—uterine cancer	0.000222	0.000435	CcSEcCtD
Ropivacaine—Paraesthesia—Epirubicin—uterine cancer	0.000222	0.000434	CcSEcCtD
Ropivacaine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000221	0.000432	CcSEcCtD
Ropivacaine—Dyspnoea—Epirubicin—uterine cancer	0.000221	0.000431	CcSEcCtD
Ropivacaine—Somnolence—Epirubicin—uterine cancer	0.00022	0.00043	CcSEcCtD
Ropivacaine—Dyspepsia—Epirubicin—uterine cancer	0.000218	0.000426	CcSEcCtD
Ropivacaine—Hypotension—Doxorubicin—uterine cancer	0.000214	0.000418	CcSEcCtD
Ropivacaine—Constipation—Epirubicin—uterine cancer	0.000212	0.000413	CcSEcCtD
Ropivacaine—Pain—Epirubicin—uterine cancer	0.000212	0.000413	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000209	0.000408	CcSEcCtD
Ropivacaine—Insomnia—Doxorubicin—uterine cancer	0.000207	0.000405	CcSEcCtD
Ropivacaine—Paraesthesia—Doxorubicin—uterine cancer	0.000206	0.000402	CcSEcCtD
Ropivacaine—Dyspnoea—Doxorubicin—uterine cancer	0.000204	0.000399	CcSEcCtD
Ropivacaine—Feeling abnormal—Epirubicin—uterine cancer	0.000204	0.000398	CcSEcCtD
Ropivacaine—Somnolence—Doxorubicin—uterine cancer	0.000203	0.000398	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000202	0.000395	CcSEcCtD
Ropivacaine—Dyspepsia—Doxorubicin—uterine cancer	0.000201	0.000394	CcSEcCtD
Ropivacaine—Urticaria—Epirubicin—uterine cancer	0.000197	0.000384	CcSEcCtD
Ropivacaine—Pain—Doxorubicin—uterine cancer	0.000196	0.000383	CcSEcCtD
Ropivacaine—Constipation—Doxorubicin—uterine cancer	0.000196	0.000383	CcSEcCtD
Ropivacaine—Body temperature increased—Epirubicin—uterine cancer	0.000196	0.000382	CcSEcCtD
Ropivacaine—Abdominal pain—Epirubicin—uterine cancer	0.000196	0.000382	CcSEcCtD
Ropivacaine—Feeling abnormal—Doxorubicin—uterine cancer	0.000189	0.000369	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000187	0.000366	CcSEcCtD
Ropivacaine—Hypersensitivity—Epirubicin—uterine cancer	0.000182	0.000356	CcSEcCtD
Ropivacaine—Urticaria—Doxorubicin—uterine cancer	0.000182	0.000355	CcSEcCtD
Ropivacaine—Abdominal pain—Doxorubicin—uterine cancer	0.000181	0.000354	CcSEcCtD
Ropivacaine—Body temperature increased—Doxorubicin—uterine cancer	0.000181	0.000354	CcSEcCtD
Ropivacaine—Asthenia—Epirubicin—uterine cancer	0.000177	0.000347	CcSEcCtD
Ropivacaine—Pruritus—Epirubicin—uterine cancer	0.000175	0.000342	CcSEcCtD
Ropivacaine—Diarrhoea—Epirubicin—uterine cancer	0.000169	0.000331	CcSEcCtD
Ropivacaine—Hypersensitivity—Doxorubicin—uterine cancer	0.000169	0.00033	CcSEcCtD
Ropivacaine—Asthenia—Doxorubicin—uterine cancer	0.000164	0.000321	CcSEcCtD
Ropivacaine—Dizziness—Epirubicin—uterine cancer	0.000164	0.00032	CcSEcCtD
Ropivacaine—Pruritus—Doxorubicin—uterine cancer	0.000162	0.000317	CcSEcCtD
Ropivacaine—Vomiting—Epirubicin—uterine cancer	0.000157	0.000307	CcSEcCtD
Ropivacaine—Diarrhoea—Doxorubicin—uterine cancer	0.000157	0.000306	CcSEcCtD
Ropivacaine—Rash—Epirubicin—uterine cancer	0.000156	0.000305	CcSEcCtD
Ropivacaine—Dermatitis—Epirubicin—uterine cancer	0.000156	0.000305	CcSEcCtD
Ropivacaine—Headache—Epirubicin—uterine cancer	0.000155	0.000303	CcSEcCtD
Ropivacaine—Dizziness—Doxorubicin—uterine cancer	0.000151	0.000296	CcSEcCtD
Ropivacaine—Nausea—Epirubicin—uterine cancer	0.000147	0.000287	CcSEcCtD
Ropivacaine—Vomiting—Doxorubicin—uterine cancer	0.000146	0.000284	CcSEcCtD
Ropivacaine—Rash—Doxorubicin—uterine cancer	0.000144	0.000282	CcSEcCtD
Ropivacaine—Dermatitis—Doxorubicin—uterine cancer	0.000144	0.000282	CcSEcCtD
Ropivacaine—Headache—Doxorubicin—uterine cancer	0.000143	0.00028	CcSEcCtD
Ropivacaine—Nausea—Doxorubicin—uterine cancer	0.000136	0.000266	CcSEcCtD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP11A1—uterine cancer	6.04e-05	0.00376	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MET—uterine cancer	5.99e-05	0.00374	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MET—uterine cancer	5.99e-05	0.00374	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	5.94e-05	0.0037	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—ERBB2—uterine cancer	5.9e-05	0.00367	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	5.9e-05	0.00367	CbGpPWpGaD
Ropivacaine—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	5.88e-05	0.00366	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MET—uterine cancer	5.78e-05	0.0036	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MET—uterine cancer	5.78e-05	0.0036	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MET—uterine cancer	5.76e-05	0.00359	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—AKR1C3—uterine cancer	5.7e-05	0.00355	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—SMAD3—uterine cancer	5.68e-05	0.00354	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—SMAD3—uterine cancer	5.43e-05	0.00339	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	5.24e-05	0.00326	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—SMAD3—uterine cancer	5.22e-05	0.00325	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—SMAD3—uterine cancer	5.22e-05	0.00325	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	5.15e-05	0.00321	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	5.09e-05	0.00317	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—CXCL8—uterine cancer	5.05e-05	0.00315	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—SMAD3—uterine cancer	5.03e-05	0.00314	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—SMAD3—uterine cancer	5.03e-05	0.00314	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.99e-05	0.00311	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	4.93e-05	0.00307	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—ERBB2—uterine cancer	4.77e-05	0.00297	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	4.75e-05	0.00296	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	4.69e-05	0.00292	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	4.66e-05	0.00291	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MET—uterine cancer	4.65e-05	0.0029	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	4.59e-05	0.00286	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—ERBB2—uterine cancer	4.56e-05	0.00284	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—VEGFA—uterine cancer	4.54e-05	0.00283	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	4.52e-05	0.00282	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP19A1—uterine cancer	4.51e-05	0.00281	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—NRAS—uterine cancer	4.49e-05	0.00279	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MET—uterine cancer	4.45e-05	0.00277	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP19A1—uterine cancer	4.44e-05	0.00277	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—ERBB2—uterine cancer	4.38e-05	0.00273	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—ERBB2—uterine cancer	4.38e-05	0.00273	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	4.36e-05	0.00272	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—EP300—uterine cancer	4.33e-05	0.0027	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MET—uterine cancer	4.28e-05	0.00267	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MET—uterine cancer	4.28e-05	0.00267	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	4.26e-05	0.00265	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—ERBB2—uterine cancer	4.22e-05	0.00263	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—ERBB2—uterine cancer	4.22e-05	0.00263	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—ERBB2—uterine cancer	4.21e-05	0.00262	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	4.2e-05	0.00262	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MET—uterine cancer	4.12e-05	0.00257	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MET—uterine cancer	4.12e-05	0.00257	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—uterine cancer	4.11e-05	0.00256	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MET—uterine cancer	4.06e-05	0.00253	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	3.96e-05	0.00247	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—KRAS—uterine cancer	3.86e-05	0.00241	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	3.85e-05	0.0024	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	3.83e-05	0.00239	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—CTNNB1—uterine cancer	3.68e-05	0.00229	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—VEGFA—uterine cancer	3.67e-05	0.00229	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—NRAS—uterine cancer	3.63e-05	0.00226	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	3.61e-05	0.00225	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	3.56e-05	0.00222	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—SMAD3—uterine cancer	3.54e-05	0.0022	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—VEGFA—uterine cancer	3.51e-05	0.00219	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—NRAS—uterine cancer	3.47e-05	0.00216	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	3.46e-05	0.00216	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	3.46e-05	0.00216	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EP300—uterine cancer	3.42e-05	0.00213	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—ERBB2—uterine cancer	3.4e-05	0.00212	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—VEGFA—uterine cancer	3.37e-05	0.0021	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—VEGFA—uterine cancer	3.37e-05	0.0021	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	3.37e-05	0.0021	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	3.36e-05	0.00209	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—NRAS—uterine cancer	3.33e-05	0.00208	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—NRAS—uterine cancer	3.33e-05	0.00208	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—HRAS—uterine cancer	3.28e-05	0.00204	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—ERBB2—uterine cancer	3.25e-05	0.00203	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—VEGFA—uterine cancer	3.25e-05	0.00203	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—VEGFA—uterine cancer	3.25e-05	0.00203	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—VEGFA—uterine cancer	3.24e-05	0.00202	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—NRAS—uterine cancer	3.21e-05	0.002	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—NRAS—uterine cancer	3.21e-05	0.002	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.2e-05	0.00199	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—NRAS—uterine cancer	3.2e-05	0.00199	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	3.13e-05	0.00195	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—ERBB2—uterine cancer	3.13e-05	0.00195	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—ERBB2—uterine cancer	3.13e-05	0.00195	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—KRAS—uterine cancer	3.12e-05	0.00195	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	3.09e-05	0.00192	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	3.04e-05	0.00189	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	3.04e-05	0.00189	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—ERBB2—uterine cancer	3.01e-05	0.00188	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—ERBB2—uterine cancer	3.01e-05	0.00188	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—KRAS—uterine cancer	2.99e-05	0.00186	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—CTNNB1—uterine cancer	2.98e-05	0.00185	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—ERBB2—uterine cancer	2.97e-05	0.00185	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.96e-05	0.00184	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MET—uterine cancer	2.9e-05	0.00181	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	2.88e-05	0.00179	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—KRAS—uterine cancer	2.87e-05	0.00179	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—KRAS—uterine cancer	2.87e-05	0.00179	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—CTNNB1—uterine cancer	2.85e-05	0.00177	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	2.84e-05	0.00177	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.78e-05	0.00173	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EP300—uterine cancer	2.77e-05	0.00172	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—KRAS—uterine cancer	2.77e-05	0.00172	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—KRAS—uterine cancer	2.77e-05	0.00172	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—KRAS—uterine cancer	2.75e-05	0.00172	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.74e-05	0.00171	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—CTNNB1—uterine cancer	2.74e-05	0.0017	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—CTNNB1—uterine cancer	2.74e-05	0.0017	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—HRAS—uterine cancer	2.65e-05	0.00165	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.65e-05	0.00165	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EP300—uterine cancer	2.65e-05	0.00165	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CTNNB1—uterine cancer	2.64e-05	0.00164	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CTNNB1—uterine cancer	2.64e-05	0.00164	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—VEGFA—uterine cancer	2.62e-05	0.00163	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.62e-05	0.00163	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.59e-05	0.00161	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—NRAS—uterine cancer	2.59e-05	0.00161	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EP300—uterine cancer	2.54e-05	0.00158	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EP300—uterine cancer	2.54e-05	0.00158	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—HRAS—uterine cancer	2.54e-05	0.00158	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—VEGFA—uterine cancer	2.51e-05	0.00156	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—NRAS—uterine cancer	2.48e-05	0.00154	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EP300—uterine cancer	2.45e-05	0.00153	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EP300—uterine cancer	2.45e-05	0.00153	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.45e-05	0.00152	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—HRAS—uterine cancer	2.44e-05	0.00152	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—HRAS—uterine cancer	2.44e-05	0.00152	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SRD5A2—uterine cancer	2.42e-05	0.00151	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NDUFB11—uterine cancer	2.42e-05	0.00151	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—VEGFA—uterine cancer	2.41e-05	0.0015	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—VEGFA—uterine cancer	2.41e-05	0.0015	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—NRAS—uterine cancer	2.38e-05	0.00148	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—NRAS—uterine cancer	2.38e-05	0.00148	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—HRAS—uterine cancer	2.35e-05	0.00147	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—HRAS—uterine cancer	2.35e-05	0.00147	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—HRAS—uterine cancer	2.34e-05	0.00146	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—VEGFA—uterine cancer	2.32e-05	0.00145	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—VEGFA—uterine cancer	2.32e-05	0.00145	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.31e-05	0.00144	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.31e-05	0.00144	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—NRAS—uterine cancer	2.29e-05	0.00143	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—NRAS—uterine cancer	2.29e-05	0.00143	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—VEGFA—uterine cancer	2.29e-05	0.00143	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—NRAS—uterine cancer	2.26e-05	0.00141	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—KRAS—uterine cancer	2.23e-05	0.00139	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—KRAS—uterine cancer	2.13e-05	0.00133	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ERBB2—uterine cancer	2.12e-05	0.00132	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.08e-05	0.0013	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—AKT1—uterine cancer	2.07e-05	0.00129	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.05e-05	0.00128	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—KRAS—uterine cancer	2.05e-05	0.00128	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—KRAS—uterine cancer	2.05e-05	0.00128	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.02e-05	0.00126	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—KRAS—uterine cancer	1.97e-05	0.00123	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—KRAS—uterine cancer	1.97e-05	0.00123	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—KRAS—uterine cancer	1.94e-05	0.00121	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—HRAS—uterine cancer	1.89e-05	0.00118	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CTNNB1—uterine cancer	1.85e-05	0.00116	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—HRAS—uterine cancer	1.81e-05	0.00113	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKR1B1—uterine cancer	1.75e-05	0.00109	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—STAR—uterine cancer	1.75e-05	0.00109	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—HRAS—uterine cancer	1.74e-05	0.00108	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—HRAS—uterine cancer	1.74e-05	0.00108	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EP300—uterine cancer	1.72e-05	0.00107	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.7e-05	0.00106	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SRD5A2—uterine cancer	1.68e-05	0.00105	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NDUFB11—uterine cancer	1.68e-05	0.00105	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—HRAS—uterine cancer	1.68e-05	0.00105	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—HRAS—uterine cancer	1.68e-05	0.00105	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—AKT1—uterine cancer	1.67e-05	0.00104	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—HRAS—uterine cancer	1.65e-05	0.00103	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—uterine cancer	1.63e-05	0.00102	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NRAS—uterine cancer	1.61e-05	0.001	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—AKT1—uterine cancer	1.6e-05	0.000997	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—AKT1—uterine cancer	1.54e-05	0.000957	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—AKT1—uterine cancer	1.54e-05	0.000957	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—AKT1—uterine cancer	1.48e-05	0.000923	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—AKT1—uterine cancer	1.48e-05	0.000923	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.43e-05	0.000888	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.43e-05	0.000888	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—KRAS—uterine cancer	1.39e-05	0.000865	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.38e-05	0.000863	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—POLD1—uterine cancer	1.37e-05	0.000856	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.31e-05	0.000815	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKR1C1—uterine cancer	1.28e-05	0.0008	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.22e-05	0.000758	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—STAR—uterine cancer	1.22e-05	0.000758	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—HRAS—uterine cancer	1.18e-05	0.000735	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—RRM2—uterine cancer	1.15e-05	0.000713	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—DCN—uterine cancer	1.11e-05	0.000693	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.1e-05	0.000685	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.1e-05	0.000685	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.05e-05	0.000653	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—AKT1—uterine cancer	1.04e-05	0.000649	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—STAR—uterine cancer	1.03e-05	0.000642	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.03e-05	0.000642	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.02e-05	0.000635	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKR1C3—uterine cancer	9.89e-06	0.000616	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—POLD1—uterine cancer	9.55e-06	0.000595	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKR1C1—uterine cancer	8.93e-06	0.000556	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—POLD1—uterine cancer	8.09e-06	0.000504	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—RRM2—uterine cancer	7.96e-06	0.000496	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKR1B1—uterine cancer	7.95e-06	0.000496	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—STAR—uterine cancer	7.95e-06	0.000496	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—DCN—uterine cancer	7.73e-06	0.000481	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—STK11—uterine cancer	7.7e-06	0.00048	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP19A1—uterine cancer	7.7e-06	0.00048	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKR1C1—uterine cancer	7.56e-06	0.000471	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP11A1—uterine cancer	7.28e-06	0.000454	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKR1C3—uterine cancer	6.87e-06	0.000428	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—RRM2—uterine cancer	6.74e-06	0.00042	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—DCN—uterine cancer	6.55e-06	0.000408	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—POLD1—uterine cancer	6.24e-06	0.000389	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.17e-06	0.000384	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKR1C1—uterine cancer	5.84e-06	0.000364	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKR1C3—uterine cancer	5.82e-06	0.000363	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MTHFR—uterine cancer	5.79e-06	0.000361	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—STK11—uterine cancer	5.36e-06	0.000334	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP19A1—uterine cancer	5.36e-06	0.000334	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—RRM2—uterine cancer	5.2e-06	0.000324	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—DCN—uterine cancer	5.05e-06	0.000315	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.76e-06	0.000297	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—STK11—uterine cancer	4.54e-06	0.000283	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.54e-06	0.000283	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.49e-06	0.00028	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.26e-06	0.000265	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.06e-06	0.000253	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTHFR—uterine cancer	4.02e-06	0.000251	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.5e-06	0.000218	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—STK11—uterine cancer	3.5e-06	0.000218	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTHFR—uterine cancer	3.41e-06	0.000212	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTEN—uterine cancer	3.22e-06	0.000201	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—EP300—uterine cancer	3.07e-06	0.000191	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3e-06	0.000187	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTHFR—uterine cancer	2.63e-06	0.000164	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CA—uterine cancer	2.27e-06	0.000142	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTEN—uterine cancer	2.24e-06	0.000139	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—EP300—uterine cancer	2.13e-06	0.000133	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTEN—uterine cancer	1.9e-06	0.000118	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKT1—uterine cancer	1.86e-06	0.000116	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—EP300—uterine cancer	1.81e-06	0.000113	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.58e-06	9.84e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTEN—uterine cancer	1.46e-06	9.12e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—EP300—uterine cancer	1.4e-06	8.7e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.34e-06	8.34e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKT1—uterine cancer	1.29e-06	8.04e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKT1—uterine cancer	1.09e-06	6.81e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.03e-06	6.43e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKT1—uterine cancer	8.44e-07	5.26e-05	CbGpPWpGaD
